Cargando…
Diabetic lung disease: fact or fiction?
Diabetes mellitus is a chronic, progressive, incompletely understood metabolic disorder whose prevalence has been increasing steadily worldwide. Even though little attention has been paid to lung disorders in the context of diabetes, its prevalence has recently been challenged by newer studies of di...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102037/ https://www.ncbi.nlm.nih.gov/pubmed/31637580 http://dx.doi.org/10.1007/s11154-019-09516-w |
_version_ | 1783511740200255488 |
---|---|
author | Kolahian, Saeed Leiss, Veronika Nürnberg, Bernd |
author_facet | Kolahian, Saeed Leiss, Veronika Nürnberg, Bernd |
author_sort | Kolahian, Saeed |
collection | PubMed |
description | Diabetes mellitus is a chronic, progressive, incompletely understood metabolic disorder whose prevalence has been increasing steadily worldwide. Even though little attention has been paid to lung disorders in the context of diabetes, its prevalence has recently been challenged by newer studies of disease development. In this review, we summarize and discuss the role of diabetes mellitus involved in the progression of pulmonary diseases, with the main focus on pulmonary fibrosis, which represents a chronic and progressive disease with high mortality and limited therapeutic options. |
format | Online Article Text |
id | pubmed-7102037 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-71020372020-03-31 Diabetic lung disease: fact or fiction? Kolahian, Saeed Leiss, Veronika Nürnberg, Bernd Rev Endocr Metab Disord Article Diabetes mellitus is a chronic, progressive, incompletely understood metabolic disorder whose prevalence has been increasing steadily worldwide. Even though little attention has been paid to lung disorders in the context of diabetes, its prevalence has recently been challenged by newer studies of disease development. In this review, we summarize and discuss the role of diabetes mellitus involved in the progression of pulmonary diseases, with the main focus on pulmonary fibrosis, which represents a chronic and progressive disease with high mortality and limited therapeutic options. Springer US 2019-10-21 2019 /pmc/articles/PMC7102037/ /pubmed/31637580 http://dx.doi.org/10.1007/s11154-019-09516-w Text en © Springer Science+Business Media, LLC, part of Springer Nature 2019 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Kolahian, Saeed Leiss, Veronika Nürnberg, Bernd Diabetic lung disease: fact or fiction? |
title | Diabetic lung disease: fact or fiction? |
title_full | Diabetic lung disease: fact or fiction? |
title_fullStr | Diabetic lung disease: fact or fiction? |
title_full_unstemmed | Diabetic lung disease: fact or fiction? |
title_short | Diabetic lung disease: fact or fiction? |
title_sort | diabetic lung disease: fact or fiction? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102037/ https://www.ncbi.nlm.nih.gov/pubmed/31637580 http://dx.doi.org/10.1007/s11154-019-09516-w |
work_keys_str_mv | AT kolahiansaeed diabeticlungdiseasefactorfiction AT leissveronika diabeticlungdiseasefactorfiction AT nurnbergbernd diabeticlungdiseasefactorfiction |